{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:22:38Z","timestamp":1775870558429,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.cllc.2011.12.004","type":"journal-article","created":{"date-parts":[[2012,3,3]],"date-time":"2012-03-03T09:00:04Z","timestamp":1330765204000},"page":"470-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption"],"prefix":"10.1016","volume":"13","author":[{"given":"Kevin","family":"Hollevoet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marijn M.","family":"Speeckaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Sofie","family":"Decavele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan P.","family":"van Meerbeeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris R.","family":"Delanghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2011.12.004_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2011.12.004_bib2","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(03)14794-0","article-title":"Mesothelin-family proteins and diagnosis of mesothelioma","volume":"362","author":"Robinson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2011.12.004_bib3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1164\/rccm.200907-1020OC","article-title":"Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma","volume":"181","author":"Hollevoet","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cllc.2011.12.004_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2011.12.004_bib5","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1200\/JCO.2009.26.9944","article-title":"Soluble mesothelin-related peptide and osteopontin as markers of response in malignant mesothelioma","volume":"28","author":"Wheatley-Price","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cllc.2011.12.004_bib6","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1097\/JTO.0b013e3182272294","article-title":"Soluble mesothelin, megakaryocyte potentiating factor, and osteopontin as markers of patient response and outcome in mesothelioma","volume":"6","author":"Hollevoet","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2011.12.004_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejca.2007.08.028","article-title":"Mesothelin targeted cancer immunotherapy","volume":"44","author":"Hassan","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2011.12.004_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cllc.2011.12.004_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1309\/F1B64CL7H8VJKEAF","article-title":"Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis","volume":"124","author":"Hassan","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cllc.2011.12.004_bib10","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1073\/pnas.96.20.11531","article-title":"Soluble member(s) of the mesothelin\/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma","volume":"96","author":"Scholler","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cllc.2011.12.004_bib11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1158\/1055-9965.EPI-05-0334","article-title":"Mesothelin variant 1 is released from tumor cells as a diagnostic marker","volume":"15","author":"Hellstrom","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cllc.2011.12.004_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1517\/17530059.1.1.137","article-title":"MESOMARK\u00ae in vitro diagnostic test for mesothelioma","volume":"1","author":"Li","year":"2007","journal-title":"Expert Opin Med Diagn"},{"key":"10.1016\/j.cllc.2011.12.004_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","article-title":"Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer","volume":"12","author":"Hassan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2011.12.004_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1378\/chest.11-0129","article-title":"The effect of clinical covariates on the diagnostic and prognostic value of soluble mesothelin and megakaryocyte potentiating factor","volume":"141","author":"Hollevoet","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.cllc.2011.12.004_bib15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1373\/clinchem.2008.121913","article-title":"Glomerular filtration rate is a confounder for determination of soluble mesothelin in serum","volume":"55","author":"Hollevoet","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.cllc.2011.12.004_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1515\/CCLM.2010.165","article-title":"Factors affecting soluble mesothelin related protein levels in an asbestos-exposed population","volume":"48","author":"Park","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.cllc.2011.12.004_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/BMI.S3927","article-title":"Assessment of confounding factors affecting the tumor markers SMRP, CA125, and CYFRA21-1 in serum","volume":"5","author":"Weber","year":"2010","journal-title":"Biomark Insights"},{"key":"10.1016\/j.cllc.2011.12.004_bib18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.lungcan.2011.01.011","article-title":"Mesothelin and kidney function: analysis of relationship and implications for mesothelioma screening","volume":"73","author":"Boudville","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2011.12.004_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ygyno.2007.04.022","article-title":"Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment","volume":"106","author":"Badgwell","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cllc.2011.12.004_bib20","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/JTO.0b013e3181e392d7","article-title":"Sensitivity of urinary mesothelin in patients with malignant mesothelioma","volume":"5","author":"Creaney","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.cllc.2011.12.004_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00365510802145141","article-title":"How to establish glomerular filtration rate in children","volume":"241","author":"Delanghe","year":"2008","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/j.cllc.2011.12.004_bib22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1172\/JCI106083","article-title":"Differentiation of glomerular, tubular, and normal proteinuria: determinations of urinary excretion of beta-2-macroglobulin, albumin, and total protein","volume":"48","author":"Peterson","year":"1969","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cllc.2011.12.004_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cccn.2004.03.037","article-title":"Alpha 1-microglobulin: clinical laboratory aspects and application","volume":"346","author":"Penders","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cllc.2011.12.004_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2008050503","article-title":"Impaired tubular uptake explains albuminuria in early diabetic nephropathy","volume":"20","author":"Russo","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.cllc.2011.12.004_bib25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cllc.2011.12.004_bib26","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.cllc.2011.12.004_bib27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1523-1755.2002.00501.x","article-title":"The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology","volume":"62","author":"Verroust","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.cllc.2011.12.004_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrneph.2010.174","article-title":"Tubular toxicity of proteinuria","volume":"7","author":"Baines","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.cllc.2011.12.004_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/10408363.2011.591366","article-title":"Immunochemically unreactive albumin in urine: fiction or reality?","volume":"48","author":"Speeckaert","year":"2011","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.cllc.2011.12.004_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","article-title":"Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care","volume":"61","author":"Launay-Vacher","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cllc.2011.12.004_bib31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/JTO.0b013e31820db377","article-title":"Serial measurements of mesothelioma serum biomarkers in asbestos-exposed individuals: a prospective longitudinal cohort study","volume":"6","author":"Hollevoet","year":"2011","journal-title":"J Thorac Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730412000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730412000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:56:03Z","timestamp":1761504963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730412000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1525730412000034"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2011.12.004","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesothelin Levels in Urine are Affected by Glomerular Leakage and Tubular Reabsorption","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2011.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}